The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  October 2018 Next
  • EFMC-ACSMEDI: Medicinal Chemistry Frontiers 2019

    June 10-13, 2019   Krakow, Poland

    This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. The EFMC - ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for this meeting will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

    Topics

    • Adding AI to the Drug Discovery Tool Box
      Session Chair
      : Carolyn Dzierba (BRISTOL-MYERS SQUIBB, United States)
    • Advances in Protein Degradation Technologies
      Session Chair
      : Daniel Harki (UNIVERSITY OF MINNESOTA, United States)
    • Chemical Biology Tools & Target Engagement Technologies
      Session Chair
      : Edgars Suna (LATVIAN INSTITUTE OF ORGANIC SYNTHESIS, Latvia)
    • Genomics in Drug Discovery : Roles for Chemistry
      Session Chair
      : Terry Moore (UNIVERSITY OF ILLINOIS, United States)
    • GPCRs : a Discovery Powerhouse
      Session Chair
      : Yves P. Auberson (NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Switzerland)
    • Matrix Metallo-Proteinases
      Session Chair
      : Krzysztof Józwiak (MEDICAL UNIVERSITY OF LUBLIN, Poland)
    • Multi-Targeted Drugs
      Session Chair
      : Andrzej Bojarski (INSTITUTE OF PHARMACOLOGY POLISH ACADEMY OF SCIENCES, Poland)
    • Opioid, Pain, Endo-Cannabinoid
      Session Chair
      : Katarzyna Kiec-Kononowicz (JAGIELLONIAN UNIVERSITY, Poland)
    • Targeted Covalent Inhibitors
      Session Chair
      : Anders Karlén (UPPSALA UNIVERSITY, Sweden)
    Organised by : European Federation for Medicinal Chemistry (EFMC)
    Organised by : Polish Society of Medicinal Chemistry (Poland)

Job portal

26/09/2018
Associate Principal Scientist Medicinal Chemist, Astrazeneca: Medicinal Chemistry Respiratory, Inflammation & Autoimmunity iMed, Gothenburg, Sweden
read more


24/09/2018
Senior Research Scientist Synthetic/Medicinal Chemistry , Astrazeneca: Medicinal Chemistry Respiratory, Inflammation & Autoimmunity iMed, Gothenburg, Sweden
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck